Related Experiment Video
Updated: Feb 22, 2026

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
Published on: March 17, 2023
Standardizing clinical trials in near-infrared fluorescence imaging: a workflow and regulatory framework proposal
Lisanne K A Neijenhuis1,2,3, Tom H Dijkhuis2, Michael J Mandella1
1Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA.
None:
Near-infrared fluorescence imaging (NIR) is an emerging imaging modality that enhances the real-time, precise visualization of (pre)cancerous tissue during surgical and endoscopic procedures. Despite its growing adoption, the lack of standardized protocols in clinical trials hinders the comparability of results and broader clinical adaptation. This manuscript identifies key factors influencing fluorescence signal variability, categorizing them into non-adaptable and adaptable. We propose a comprehensive workflow and guidelines to standardize clinical trial protocols, ensuring reproducibility and facilitating regulatory approval. As a Perspective, we outline a standardization framework-rather than new clinical datasets-to advance NIR imaging toward routine clinical use and improved patient outcomes.
More Related Videos
11:05Tissue-simulating Phantoms for Assessing Potential Near-infrared Fluorescence Imaging Applications in Breast Cancer Surgery
Published on: September 19, 2014
04:44Author Spotlight: Enhancing Vascular Function and Physical Capacity in Cardiovascular Disease Through Novel Interventions and NIRS Technology
Published on: March 22, 2024
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...